Short sellers made bold new bets this week — while retreating just as fast elsewhere.
Replimune saw the sharpest SI jump among large caps. Its SI % of Free Float hit 37.8%, up 10.4 percentage points in just seven days. Bears are clearly nervous about the oncology biotech's next catalyst.
Wolfspeed remains the most crowded short among mid-cap names. SI stands at 85.2% of FF, up another 6.9pp this week. Zero shares are available to borrow. That combination — extreme shorts with no availability — makes a squeeze mathematically plausible.
The week's biggest unwind happened in SpaceX. Short interest collapsed 14.5pp to 22% of FF as Harvard's $2.2bn stake grabbed headlines and bullish sentiment surged. Shorts fled.
Chewy also saw a sharp cover — SI fell 12.3pp to 66.4% of FF. Availability sits at 466%, meaning borrow is plentiful. That cushion limits squeeze risk despite the still-elevated reading.
Campbell's is a quieter mover worth watching. SI climbed nearly 4pp to as the food giant faces margin pressure. Bears are betting the defensive trade turns offensive.
Galectin Therapeutics holds the highest short score at 90, with 68.9% of FF shorted and availability near 12%. That is a powder keg.
This is not financial advice.
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
